You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Your Nucala treatment

This page is specifically for patients who have been prescribed Nucala. If you are not a patient who has already been prescribed Nucala, please return to the public website.

Why have I been prescribed this medication?

NUCALA is a treatment option for people who have severe refractory eosinophilic asthma. The decision to prescribe you this medication was based on an assessment of:

Lungs

You current asthma symptoms, including the number of asthma attacks.

inhaler

The types of medications you take.

test tube

Routine blood tests.

Should I continue my existing medication

  • Yes. Nucala is an add-on treatment, which means you should continue to take your other medications as prescribed by your doctor. 
  • It is recommended that all patients with asthma have an asthma action plan. 
  • If you have any questions, please ask your doctor or nurse at your next appointment.

How will I know if Nucala is working for me?

  • All asthma patients should have an asthma action plan. Download your asthma action plan here and fill it in with your doctor or nurse: www.asthma.org.uk/advice/resources/#action-plans
  • Keep a written record of your progress to share with your doctor.

Nucala is a registered trademark of the GlaxoSmithKline group of companies

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441.